When used in conjunction with other risk factors, the 6 distinct blood pressure patterns were able to accurately predict and stratify risk of hypertensive disorders of pregnancy regardless of race or ethnicity.
A handful of blood pressure patterns in the first half of pregnancy may be able to determine risk of preeclampsia and gestational hypertension, suggest new study findings published in the Journal of the American Heart Association.
When used in conjunction with other risk factors, the 6 distinct blood pressure patterns—both initial levels and changes in patterns over time—were able to accurately predict and stratify risk of pregnancy regardless of race or ethnicity.
“Hypertensive disorders in pregnancy are leading causes of morbidity and mortality, particularly in people of color,” Kari L. Carldon, MD, associate executive director of The Permanente Medical Group, said in a statement. “Identifying risk factors and then implementing a risk stratification program and treatment plan could have a huge impact for both the pregnant person and infant, dramatically reducing the changes of adverse outcomes.”
The researchers of the study further highlighted the feasibility of implementing a risk stratification program based on their findings, as blood pressure measurements do not require biomarker testing or biophysical parameters.
The group analyzed blood pressure measurements and other data from the electronic medical records of approximately 250,000 healthy pregnant patients who gave birth at Kaiser Permanente Northern California hospitals between 2009 and 2019, all of whom were considered to be at low to moderate risk of developing hypertensive disorders of pregnancy based on US Preventive Services Task Force criteria. Patients with high-risk conditions, such as prior chronic hypertension, liver disease, or kidney disease, were excluded from the study.
From these data, the researchers developed and validated the 6 blood pressure trajectories, which elicited “excellent” discrimination, with C-statistics ranging from 0.731 to 0.770. The observed discrimination, explained the researchers, was superior to that observed when using risk factors alone (0.688-0.695).
Three of the 6 blood pressure trajectories observed in the first 20 weeks of pregnancy were able to identify nearly 3 in 4 patients (74%) who subsequently developed preeclampsia in the latter half of their pregnancy as well as 82% of gestational hypertension outcomes in more than half (52%) of the study group.
“These findings are likely to influence practice standards. Current guidelines recommend that patients with only one moderate risk factor are to be ‘considered’ for treatment with [low-dose aspirin administration],” highlighted the researchers.
“The systolic [blood pressure trajectory] patterns based on 3 or 4 BP measurements in the first half of pregnancy reclassified a substantial proportion of patients, considered as moderate risk under current guidelines’ criteria, as having lower risk for preeclampsia and gestational hypertension. Furthermore, the effectiveness of the early pregnancy [blood pressure trajectory] patterns to discriminate high-risk individuals within an ostensibly low-to-moderate risk population is a major advancement in precision care without expensive assessments.”
Across the study cohort, 0.4% (n = 1008), 4.3% (n = 10,766), and 4.6% (n = 11,514) of patients developed early-onset preeclampsia, later-onset preeclampsia, and gestationa; hypertension, respectively. The absolute observed risk of preeclampsia ranged from 0.5% to over 15% while risk of gestational hypertension ranged from 0.4% to 17.6% based on race, ethnicity, nulliparity, and maternal obesity, among other factors. The findings suggest that even within populations of patients considered to be at low to moderate risk, there are subsets of patients at higher risk, including those with common risk factors like nulliparity and obesity.
Reference
Gunderson E, Greenberg M, Sun B, et al. Early pregnancy systolic blood pressure patterns predict early- and later-onset preeclampsia and gestational hypertension among ostensibly low-to-moderate risk groups. J Am Heart Assoc. Published online July 12, 2023. doi:10.1161/JAHA.123.029617
Contributor: More Informed Management of Preeclampsia Is Necessary
November 29th 2023At present, it is difficult for clinicians to identify patients at greatest risk for developing preeclampsia with severe features and tailor treatment plans for them; this difficulty increases costs significantly.
Read More
RHC Still Recommended Over Echocardiography for Detecting COPD-PH
November 20th 2023In a single-center, retrospective analysis, echocardiography demonstrated low sensitivity but high specificity for diagnosing pulmonary hypertension (PH) in advanced chronic obstructive pulmonary disease (COPD).
Read More
Advancements Needed in Research on SCD-Associated Pulmonary Hypertension
November 18th 2023To stress the importance of considering pulmonary complications in sickle cell disease (SCD), researchers compiled an overview on the state of research and available treatment options for patients with SCD associated with pulmonary hypertension.
Read More
Personalized Medicine Would Offer Great Benefits to Patients With PAH
November 10th 2023In a recent review, researchers overviewed the challenging aspects of treating pulmonary arterial hypertension (PAH), highlight the genetic and etiological variability, and advocate for research to expand personalized medicine.
Read More
SPHERE Registry Data Highlight Racial, Ethnic Disparities in PAH Treatment, Outcomes
October 31st 2023Data from the SPHERE registry revealed racial and ethnic discrepancies in disease severity, comorbidities, and outcomes experienced by patients with pulmonary arterial hypertension (PAH) receiving selexipag.
Read More